USANA Health Sciences, Inc. (NYSE:USNA) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. cut its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 21.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 140,856 shares of the company's stock after selling 38,166 shares during the period. Charles Schwab Investment Management Inc. owned 0.74% of USANA Health Sciences worth $5,055,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. R Squared Ltd purchased a new stake in USANA Health Sciences during the fourth quarter worth $28,000. Safe Harbor Fiduciary LLC purchased a new stake in shares of USANA Health Sciences during the 3rd quarter worth $30,000. Centiva Capital LP purchased a new stake in shares of USANA Health Sciences during the 3rd quarter worth $213,000. Quest Partners LLC bought a new stake in USANA Health Sciences during the third quarter valued at about $250,000. Finally, Exchange Traded Concepts LLC grew its stake in USANA Health Sciences by 11.3% in the fourth quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company's stock valued at $308,000 after purchasing an additional 869 shares during the last quarter. 54.25% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Jim Brown sold 5,000 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $29.47, for a total value of $147,350.00. Following the transaction, the chief executive officer now owns 15,716 shares in the company, valued at approximately $463,150.52. This represents a 24.14 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Joshua Foukas sold 5,732 shares of the firm's stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $32.54, for a total transaction of $186,519.28. The disclosure for this sale can be found here. Insiders sold 15,920 shares of company stock worth $500,285 in the last 90 days. Insiders own 0.33% of the company's stock.

Remove Ads

USANA Health Sciences Trading Down 1.1 %

Shares of USNA stock traded down $0.32 during trading hours on Friday, reaching $27.84. 121,796 shares of the company's stock were exchanged, compared to its average volume of 111,939. USANA Health Sciences, Inc. has a 1 year low of $26.19 and a 1 year high of $49.78. The stock has a market cap of $526.37 million, a PE ratio of 9.84, a PEG ratio of 0.93 and a beta of 0.98. The stock's fifty day moving average price is $31.15 and its two-hundred day moving average price is $35.08.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.15. The company had revenue of $213.61 million for the quarter, compared to the consensus estimate of $208.82 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. On average, equities analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

USNA has been the subject of several analyst reports. StockNews.com lowered shares of USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Sidoti lowered shares of USANA Health Sciences from a "strong-buy" rating to a "hold" rating in a report on Tuesday, February 18th. Finally, DA Davidson reduced their price target on USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating on the stock in a research report on Thursday, February 27th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.